CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Eikon Therapeutics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Eikon Therapeutics Inc
230 Harriet Tubman Way
Phone: (302) 658-7581p:302 658-7581 MILLBRAE, CA  94030  United States Ticker: EIKNEIKN
Business Summary
Eikon Therapeutics, Inc. is a drug discovery and development company. The Company is focused on live-cell super-resolution microscopy and engineering for drug discovery. It tracks and measures the real-time movement of individual proteins in living cells to increase the understanding of disease biology and discover differentiated therapeutics.
(Source: PRESS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer, Director Roger M.Perlmutter 73 1/1/2021 1/1/2021
Chief Financial Officer AlfredBowie 44 1/1/2025
Chief Operating Officer Michael A.Klobuchar 50 1/1/2024 1/1/2024
7 additional Officers and Directors records available in full report.

Business Names
Business Name
EIKN
EIKON THERAPEUTICS

General Information
Outstanding Shares: 21,403,390 (As of 12/31/2024)
Stock Exchange: NASD
Federal Tax Id: 842807586
Fax Number: (302) 655-5049


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, February 18, 2026